Fatima A. Jamali

Internal Medicine

2560 Samaritan Dr
Las Cruces, NM 88001

Last Updated: 11/08/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Functional improvements correlate with enhanced quality of life following mesenchymal stromal cell therapy in chronic spinal cord injury.

Functional improvements correlate with enhanced quality of life following mesenchymal stromal cell therapy in chronic spinal cord injury.

Journal: Scientific reports

Published: May 05, 2025

Parkinson's Disease Database in the Middle East, North Africa, and South Asia Countries.

Parkinson's Disease Database in the Middle East, North Africa, and South Asia Countries.

Journal: International journal of public health

Published: October 05, 2024

Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical Study.

Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Multiple Sclerosis Patients: Phase I/II Dose-Finding Clinical Study.

Journal: Cell transplantation

Published: March 07, 2024

Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I/II study.

Safety and potential efficacy of expanded mesenchymal stromal cells of bone marrow and umbilical cord origins in patients with chronic spinal cord injuries: a phase I/II study.

Journal: Cytotherapy

Published: September 03, 2023

Safe Reversal of Motor and Sensory Deficits by Repeated High Doses of Mesenchymal Stem Cells in a Patient with Chronic Complete Spinal Cord Injury.

Safe Reversal of Motor and Sensory Deficits by Repeated High Doses of Mesenchymal Stem Cells in a Patient with Chronic Complete Spinal Cord Injury.

Journal: The American journal of case reports

Published: May 13, 2023

A comparative study of the capability of MSCs isolated from different human tissue sources to differentiate into neuronal stem cells and dopaminergic-like cells.

A comparative study of the capability of MSCs isolated from different human tissue sources to differentiate into neuronal stem cells and dopaminergic-like cells.

Journal: PeerJ

Published: October 27, 2021

Validation of the Arabic Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.

Validation of the Arabic Version of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.

Journal: Movement disorders : official journal of the Movement Disorder Society

Published: September 04, 2021

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study.

A New Tool for Safety Evaluation and a Combination of Measures for Efficacy Assessment of Cotransplanting Human Allogenic Neuronal Stem Cells and Mesenchymal Stem Cells for the Treatment of Parkinson Disease: Protocol for an Interventional Study.

Journal: JMIR research protocols

Published: April 16, 2021

The effect of stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis: A comparative study.

The effect of stem cell therapy and comprehensive physical therapy in motor and non-motor symptoms in patients with multiple sclerosis: A comparative study.

Journal: Medicine

Published: August 28, 2020

Anti-oncogenic activities exhibited by paracrine factors of MSCs can be mediated by modulation of KITLG and DKK1 genes in glioma SCs in vitro.

Anti-oncogenic activities exhibited by paracrine factors of MSCs can be mediated by modulation of KITLG and DKK1 genes in glioma SCs in vitro.

Journal: Molecular therapy oncolytics

Published: August 04, 2020

An insight into the whole transcriptome profile of four tissue-specific human mesenchymal stem cells.

An insight into the whole transcriptome profile of four tissue-specific human mesenchymal stem cells.

Journal: Regenerative medicine

Published: February 01, 2019

Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy.

Mesenchymal stem cells and conditioned media in the treatment of multiple sclerosis patients: Clinical, ophthalmological and radiological assessments of safety and efficacy.

Journal: CNS neuroscience & therapeutics

Published: June 03, 2017

Showing 1-12 of 12

Last Updated: 11/08/2026